Bio-Rad Laboratories (BIO) Long-Term Debt Issuances (2010 - 2022)
Bio-Rad Laboratories' (BIO) quarterly Long-Term Debt Issuances came in at -$20000.0 in Q4 2022, down 100.0% quarter-over-quarter from $1.2 billion in Q1 2022.
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Long-Term Debt Issuances (2010 - 2022) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Long-Term Debt Issuances for 2 consecutive years, with -$20000.0 the latest figure, recorded in Q4 2022.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to -$20000.0 in Q4 2022; TTM through Sep 2023 was -$20000.0, a 100.0% decrease from a year earlier, with the FY2022 full-year figure at $1.2 billion, changed N/A from the prior year.
- Long-Term Debt Issuances was -$20000.0 for Q4 2022 at Bio-Rad Laboratories, down from $1.2 billion in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $1.2 billion in Q1 2022 and troughed at -$20000.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | - |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 6.56 Bn |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 600.00 Mn |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | - |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | - |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | - |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -20,000.00 |
| Mar 31, 2022 | 1.19 Bn |
| Dec 31, 2010 | 422.63 Mn |